MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

How much does botulinum toxin injection interval impact upon patient satisfaction in the routine treatment of cervical dystonia?

T. Chung, D. Charles, C. Colosimo, V. Misra, P. Maisonobe, S. Om (São Paulo, Brazil)

Meeting: 2018 International Congress

Abstract Number: 717

Keywords: Botulinum toxin: Clinical applications: dystonia

Session Information

Date: Sunday, October 7, 2018

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Hall 3FG

Objective: Evaluate the impact of injection interval on satisfaction with botulinum toxin-A (BoNT-A) treatment in cervical dystonia (CD) patients who have been treated for 1 year.

Background: Patient ratings of treatment satisfaction are strongly correlated with willingness to continue therapy. Little is known about the impact of BoNT-A injection interval on satisfaction in patients on established treatment.

Methods: INTEREST IN CD2 (NCT01753349) is an observational, routine-practice study following patients with CD treated with BoNT-A. This analysis compared the level of satisfaction with symptom control for subjects on established BoNT-A treatment (all subjects had completed 1-year follow-up), categorized by their most recent injection interval. Satisfaction was assessed as: (1) ‘Today satisfaction’, subjects rated their current satisfaction (end of treatment cycle), (2) ‘Highest satisfaction’, subjects rated their highest level of satisfaction over the previous cycle.

Results: Of 819 subjects included in this analysis, 498 (60.8%) had an injection interval of 12-16 weeks, 307 (37.5%) with >16-week interval and 14 (1.5%) with <12-week interval. Patient satisfaction with their symptom control at the end of the treatment cycle (Today satisfaction) was consistently lower than satisfaction at peak effect during the last cycle (Highest satisfaction) [table1]. However, levels of satisfaction were similarly high across all groups (95% CI intervals overlapped).

Conclusions: As can be expected, patient satisfaction is higher at peak effect than at the end of treatment cycle when therapeutic efficacy is waning. In this study, the length of treatment cycle did not impact patient satisfaction with symptom control (even at end of the treatment cycle). Longer injection intervals, which will not negatively affect patient satisfaction may therefore be of interest for social (fewer appointments and injections) and economic (reduced drug costs, less physician time) reasons.

To cite this abstract in AMA style:

T. Chung, D. Charles, C. Colosimo, V. Misra, P. Maisonobe, S. Om. How much does botulinum toxin injection interval impact upon patient satisfaction in the routine treatment of cervical dystonia? [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/how-much-does-botulinum-toxin-injection-interval-impact-upon-patient-satisfaction-in-the-routine-treatment-of-cervical-dystonia/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/how-much-does-botulinum-toxin-injection-interval-impact-upon-patient-satisfaction-in-the-routine-treatment-of-cervical-dystonia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley